These Standards are adopted pursuant to the provisions of Article 7 and Article 10 of the Charges and Fees Act.
These Standards are applicable to drug advertisements that apply for review in accordance with the regulations of the Pharmaceutical Affairs Act.
The standards for charging fees to review drug advertisements are as follows：
I. The review fee charged for new applications of advertisement shall be NT$5,400 per application.
II. The review fee charged for applications of extension shall be NT$2,000 per application.
III. For reissuing approved forms that have been lost, NT$1,500 shall be charged per application.
IV. The review fee charged for letter of inquiry about drug advertisement shall be NT$2,500 per application.
These Standards shall be implemented from 1 January 2021.